Top Markets
#1 Tornado Cash Tornado Cash +5.42%
#2 MVL MVL +3.98%
#3 Story Story +3.25%
#4 Dual Dual +2.86%
#5 TENDIES TENDIES +2.76%
#6 UnifAI Network UnifAI Network +2.62%
#7 Figure Heloc Figure Heloc +2.55%
#8 WAX WAX +2.47%
#9 KOTAI KOTAI +2.19%
#10 Seeker Seeker +2.13%
Coin of the day
Tornado Cash Tornado Cash
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
AP Biosciences Inc AP Biosciences Inc

AP Biosciences Inc

6945
Classificação em ações #16392
AP Biosciences Inc. is a pioneering clinical-stage biopharmaceutical company... AP Biosciences Inc. is a pioneering clinical-stage biopharmaceutical company dedicated to the research and development of bispecific antibody drugs, aiming to fulfill critical unmet medical needs. Its robust pipeline features several promising candidates: Leading the pack, IBI302 is in Phase III clinical trials for the treatment of neovascular age-related macular degeneration (nAMD). Further along, AP505 is undergoing Phase I clinical trials for various solid tumors. AP203, also in Phase I, is being investigated for non-small cell lung cancer, head and neck squamous cell carcinoma, and esophageal squamous cell carcinomas. In earlier development, AP402 is currently in the pre-clinical research phase, focusing on breast cancer patients. Additionally, AP601 is also in pre-clinical research, targeting a broader spectrum of malignancies including lung cancer, pancreatic cancer, bladder cancer, ovarian cancer, and other solid tumors. Founded in 2013, the company maintains its headquarters in Taipei City, Taiwan.
Preço da ação
$3.06
Valor de mercado
$296.40M
Variação (1 dia)
-2.24%
Variação (1 ano)
-22.64%
País
TW
Negociar AP Biosciences Inc (6945)

Categoria

Healthcare
Histórico de preços das ações de AP Biosciences Inc (6945)
Preço de fecho mais alto: $3.06 em 2026-09-01

Preço de fecho mais baixo: $2.10 em 2023-07-01
Histórico de preços das ações da AP Biosciences Inc de 2023 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -13.12%
2025 237.19%
2024 4.26%
2023 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.15 36.70%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.33%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.87 536.09%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -10.53%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $748.60 6.90%
CH